07:00, 14 November 2024
Words by Cheyanne Bryan, Editorial and Campaign Marketing Executive, London
Today marks the global campaign that is World Diabetes Day. We recognise this day to encourage global conversation around diabetes, its prevention, management, and the challenges faced by those living with the condition.
Led by the International Diabetes Federation (IDF) and supported by various organisations worldwide, we at Smiley News would like to do our part to build conversations and share 4 new innovations to help the lived experience of those with diabetes.
Early-stage research has shown promise for a new 'smart' insulin that activates only when blood sugar levels are high in animals, offering potential benefits for simplifying diabetes management. The newly developed insulin, NNC2215, features a molecular switch that responds to fluctuating blood sugar levels by either staying off or lowering blood sugars as needed. While further testing in humans is required, these findings published in Nature suggest a promising advancement in insulin technology for individuals with diabetes.
In a pioneering move by the NHS, tens of thousands of individuals with type 1 diabetes in England will receive an 'artificial pancreas' device that monitors blood glucose levels and automatically administers insulin, potentially eliminating the need for manual injections. This innovative technology aims to enhance diabetes management, prevent severe complications, and improve the quality of life for those with the condition, with NHS England allocating £2.5 million to support the initiative following a successful pilot program benefiting 835 patients.
Diabetes distress, a common feeling of being overwhelmed by the challenges of managing diabetes, affects many individuals with type 1 diabetes. Recognisng the importance of addressing this issue, Diabetes UK has initiated a research project led by Professor Jackie Sturt to develop a new program called D-stress. This innovative approach aims to detect, manage, and prevent diabetes distress, potentially revolutionising diabetes care by focusing on the emotional well-being of those living with the condition. Through collaboration with individuals with type 1 diabetes and healthcare professionals, the project seeks to create a unique treatment that could improve quality of life and blood sugar levels.
In a groundbreaking stem-cell therapy trial for type 1 diabetes, a woman received treatment using her own cells, leading to her no longer requiring insulin 75 days post-procedure. Researchers in China found that the stem-cell derived islet cells successfully engrafted in her abdomen. This promising outcome has prompted the enrollment of additional participants in this trial and similar stem-cell based therapies for both type 1 and type 2 diabetes are also under development and in clinical trials.
At Smiley Movement, we like to elevate the work of charities across the world. Here are three charities whose causes align with the themes in this article.
Diabetes UK. This charity Diabetes UK's mission is to find a cure for diabetes. They offer support groups, information, and campaigns to change policies and attitudes around diabetes. Find out more.
The Insulin Dependent Diabetes Trust (IDDT). This is an independent charity committed to supporting individuals with insulin-dependent diabetes and advocating for their needs. Learn more here.
World Diabetes Foundation. This is a global organisation committed to preventing and treating diabetes worldwide through sustainable programs and partnerships. Support them here.
